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Abstract: The programming of deep brain stimulation (DBS) parameters for tremor is laborious
and empirical. Despite extensive efforts, the end-result is often suboptimal. One reason for this
is the poorly understood relationship between the stimulation parameters’ voltage, pulse width,
and frequency. In this study, we aim to improve DBS programming for essential tremor (ET) by
exploring a new strategy. At first, the role of the individual DBS parameters in tremor control was
characterized using a meta-analysis documenting all the available parameters and tremor outcomes.
In our novel programming strategy, we applied 10 random combinations of stimulation parameters
in eight ET-DBS patients with suboptimal tremor control. Tremor severity was assessed using
accelerometers and immediate and sustained patient-reported outcomes (PRO’s), including the
occurrence of side-effects. The meta-analysis showed no substantial relationship between individual
DBS parameters and tremor suppression. Nevertheless, with our novel programming strategy,
a significantly improved (accelerometer p = 0.02, PRO p = 0.02) and sustained (p = 0.01) tremor
suppression compared to baseline was achieved. Less side-effects were encountered compared to
baseline. Our pilot data show that with this novel approach, tremor control can be improved in
ET patients with suboptimal tremor control on DBS. In addition, this approach proved to have a
beneficial effect on stimulation-related complications.
Keywords: DBS; tremor; stimulation parameters; DBS programming algorithm; DBS side effects;
thalamic nucleus; zona incerta
1. Introduction
Essential tremor (ET) is the most prevalent movement disorder, affecting up to 4% of the adult
population [1]. Medical management of ET is limited and is often unsatisfactory [2]. For medically
refractory cases, deep brain stimulation (DBS) may be considered. The long-term safety and efficacy of
DBS are well-established [3], although it is not certain whether its initially reported superior tremor
suppression is also achieved in successive cohorts [4]. Additionally, evidence shows that 33 out of 45
patients in one study (73.3%) reported waning tremor control at a mean time of 18.8 ± 15.1 months
postoperatively [5].
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The outcome of ET-DBS depends on several factors. Preoperative considerations include but are not
limited to tremor characteristics [6] and the anatomical target of the intervention [7,8]. Postoperatively,
optimal tremor reduction is achieved with time-consuming programming. The current strategy for
symptom control starts with a standardized evaluation of several conventional stimulation parameters,
representing the highest probability for success. Pulse widths with an estimated chronaxie (i.e.,
the minimum time for exciting a neural element using half the intensity to elicit a threshold response,
for review see [9]) for myelinated axons in ET-DBS average 40–90 µs [10]. As far as frequency
is concerned, it should be noted that during the first application of DBS, 50 Hz stimulation was
considered as high-frequency stimulation [11]. Ever since, a broad range of stimulation frequencies up
to 185 Hz has been explored, although there is no clear relation between the stimulation frequency
and degree of tremor suppression. All parameters are further titrated in a ‘trial and error’ fashion,
until satisfactory tremor suppression is achieved in the absence of side effects. In practice, this requires
extensive programming sessions, in which patient fatigue may hamper achieving the desired results.
Empirical titration becomes additionally challenging when conventional DBS parameters do not
address individual requirements [12] or become subject to tremor habituation [13], requiring broader
parameter searches than feasible. A clear understanding of the therapeutic role of the stimulation
parameters is therefore essential. Unfortunately, the relation of any of the stimulation parameters and
degree of tremor suppression remains insufficiently understood. A study exploring high-frequency
stimulation as a putative cause for worsening balance in ET patients demonstrated that reducing
stimulation frequency from 170–185 to 130 Hz after optimizing tremor control improved axial cerebellar
signs [14]. In addition, therapeutic DBS intensity levels suppress tremor, while supra-therapeutic
amplitudes and pulse-widths cause (gait) ataxia [15,16]. The deleterious effect of excessive stimulation
translates thus into a narrow therapeutic window for tremor suppression.
Despite efforts to individualize and improve DBS programming [17,18], these are either not
robust enough or are too technically challenging to be routinely applied in clinical practice. In the
absence of an explicit, validated programming protocol, the process remains laborious and outcomes
inconsistent, with average tremor reduction varying between 33 and 74% [2]. Outcomes may be
improved with expert programming, shown to provide significant improvement in 37% of patients
and partial improvement in 15% [12].
In this study, we aim to improve DBS programming protocols. We start by reviewing all
documented DBS parameters and tremor outcomes in ET, with the aim to gain insight into the
advancement of DBS programming over time, as well as to characterize the role of the DBS-parameters
(voltage, pulse width, and frequency). Next, as a proof of concept, we introduce a novel approach for a
timely and thorough exploration of the DBS parameter space in individual patients.
2. Methods
2.1. Meta-Analysis
2.1.1. Search Strategy and Selection Criteria
We conducted a PubMed search for DBS parameters in ET on 05/03/2018, using the following
string: (“DBS” OR “Deep Brain Stimulation”) AND (“essential tremor”). The search was conducted
by two independent reviewers (DB and MO). Articles written in English, containing the key terms
“DBS” or “stimulation” and “essential tremor” were included for full text screening. Animal studies,
experiments in which patients had co-existing movement disorders (e.g., Parkinson’s disease), as well
as review articles were excluded from further analysis. For full text screening the following exclusion
criteria were applied: (1) either stimulation parameters or outcomes were not reported; (2) interventions
following failed DBS or thalamotomy (the latter might still exert therapeutic effects); (3) reports earlier
than three months post-operatively (when the microlesion effect might influence tremor) or with
unspecified follow-up moment; (4) cohorts already reported; (5) irretrievable articles; (6) pooled data
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of ET with Parkinson’s patients; (7) IPG malfunctions. Review articles were checked for any relevant
missing articles. The remaining articles were selected for data extraction.
2.1.2. Data Extraction
From each relevant study, the following data were extracted: publication year, size of patient
sample, DBS target, average stimulation voltage, pulse width and frequency, tremor reduction, scale of
tremor measurement, follow-up moment and side-effects. Side-effects were categorized as paresthesia,
gait and balance problems, ataxia, dysarthria and diplopia or visual disturbances.
2.1.3. Data Synthesis
Data were recorded as mean± standard deviation. For analysis, weighted values of the stimulation
parameters and tremor outcomes were used. Reports of tremor suppression were heterogenous not
only in terms of tremor scale, but also follow-up duration. Therefore, tremor outcomes were converted
to percentages of tremor reduction and the primary outcome time point was used for each study.
Given that the tremor measurements were performed at various follow-up durations, time might have
possibly exerted an effect on the tremor outcomes owing to disease progression or tremor adaption.
For this reason, follow-up durations were split into quartiles and the corresponding tremor outcomes
were compared between the four groups.
2.1.4. Comparisons
To characterize the explored range of stimulation parameters and the evolution of tremor outcomes
from the first application of DBS for tremor (1987) until the present, we correlated these values with time,
i.e., corresponding publication year. Next, we explored the relationship between voltage, pulse width,
frequency and tremor control. We also documented the encountered side-effects and correlated their
frequency with the corresponding stimulation parameters.
2.2. Experimental DBS Programming
2.2.1. Patients
Eight consecutive patients treated with bilateral DBS for medically refractory ET participated in
the study. Prior medical treatment included propranolol, primidone and topiramate, or a combination
of the three. The efficacy of the treatment has been thoroughly reviewed before deeming the patient
therapy-resistant and discussed multi-disciplinarily to establish the indication for DBS. All patients
were implanted (Medtronic model 3387 lead, contacts 1.5 mm in length, spaced 3 mm center-to-center;
Medtronic, Inc.) using the Leksell G frame (Elekta, Stockholm, Sweden). Accurate electrode positioning
was tested using intra-operative macrostimulation (up to 5 V, with 60 µs pulses and a frequency of
185 Hz) and was confirmed by postoperative MRI (Philips Intera, Eindhoven, the Netherlands) and/or
CT-scanning (Sensation 64, Siemens, Erlangen, Germany). The post-implantation CT images were
fused with preoperative 3T-MRI images using BrainLAB software (BrainLAB, Heimstetten, Germany).
The electrode configurations and stimulation parameters had been reviewed at length and optimized
by using Medtronic’s 8840 N’Vision Clinician Programmer (Medtronic, Inc., Northridge, CA, USA),
according to the best current practice [19]. None of the patients were on any medication for tremor
following DBS. Patients were recruited at the outpatient neurological department at the University
Medical Centre Groningen (UMCG). The experimental procedure was approved by the medical ethical
review board of the UMCG (registration number 2017406) and deemed “care as usual”. Under these
circumstances, written informed consent was not required.
2.2.2. Experimental Paradigm
The experimental paradigm started with a baseline tremor measurement, using the current
stimulation parameters. Tremor was assessed in various arm postures and quantified by an in-house
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developed accelerometer (UMCG, Groningen, The Netherlands). For each posture, the total distance
amplitude (TDamp) was calculated over 5 s by a custom-written script in LabVIEW (2014 SP1) and was
used to assess tremor severity. This was done by calculating the second integral of the accelerometer
signal. After the baseline measurement, the posture in which tremor was most severe, was used for the
adjustment of DBS parameters.
In this posture, 10 random combinations of stimulation parameters (voltage, pulse width and
frequency) were tested. These combinations were generated by a custom-written script in MATLAB
(version R2014a, MathWorks, MA, USA), for each patient individually. The ranges from which the
stimulation parameters were randomly extracted were as follows: voltage 1.5–4 V with intervals of 0.1 V;
pulse width 60–240 µs with intervals of 10µs and frequency 60–185 Hz with intervals of 5 Hz. The script
selected at random one voltage, one pulse width and one frequency, from a pool of 12,844 theoretical
combinations. The process was repeated 10 times for every patient. For each experimental combination,
a 5s accelerometer recording was performed once the effects of the previous settings disappeared.
Patients also indicated whether stimulation felt better in terms of tremor control compared to baseline.
If side-effects emerged, stimulation was not further increased (thus attaining a pseudorandom set of
parameters). However, the transition between combinations was done systematically to maximize
the chance of employing a given set of parameters. Namely, we identified the parameters that
needed to be lowered or increased in the subsequent setting. Given that higher current charges are
more likely to cause side-effects, the parameters were prioritized as follows: parameter requiring the
greatest decrements, followed by eventual lesser decrements, least increments and greatest increments,
respectively. Therefore, parameters requiring decreases were adjusted first. If the remaining parameters
needed to be increased, the one requiring the smallest increase was adjusted first. If the remaining
changes were to cause side-effects, increments would be stopped, and the final combination would be
noted. By applying this system, the pseudo character of the random parameters was deemed by the
patient safety and not by the clinician’s bias.
In case the new stimulation parameters led to improved tremor control and/or less side-effects
compared to the baseline settings, patients maintained these parameters. To evaluate whether the new
empirical settings retained tremor control, patients were approached by telephone 6–17 weeks later.
Patients indicated whether tremor control was similar, better or worse compared to baseline settings
and whether side-effects had emerged.
2.2.3. Evaluation of the Experimental Settings
The combinations of stimulation parameters that led to the best tremor reduction were identified
by the individual ratings of the patients (subjective) and the accelerometer signal (objective). The effect
on tremor of the best subjective and objective random stimulation parameters was compared to that
of the baseline settings. Medium-term efficacy (i.e., beyond the clinical setting) was determined by
contrasting the patient-reported improvements to baseline tremor control. Next, the subjective and
objective stimulation parameters were compared to baseline settings to determine whether tremor
control was achieved with significantly different parameters or levels of total electrical energy delivered
(TEED, [20]).
3. Statistical Analysis
Statistical analysis was performed using SPSS (SPSS IBM version 23.0, Armonk, NY, USA).
Data normality was tested with the Kolmogorov–Smirnov test. For correlations, Pearson’s correlation
or Spearman’s rank-order correlation were used accordingly and reported together with the percentage
of explained variance (r2). In the case of within-subject measurements, paired sample t-tests were used
for normally distributed data and two-tailed Wilcoxon signed-rank tests for nonparametric distributions.
For nonparametric, independent comparisons, the Kruskal–Wallis test was used. Significance was set
at p < 0.05.
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4. Results
4.1. Meta-Analysis
4.1.1. Study Inclusion and Data Characteristics
Our PubMed search yielded a total of 777 studies. Four duplicates were removed,
leaving 773 studies for title and abstract screening. Here, 538 studies did not fulfil the inclusion
criteria. The remainder of 235 full-text studies were assessed for eligibility. Four additional studies
were identified through cross-reference screening and added to the eighty-three studies selected
for data extraction, involving 1652 patients (Figure 1, Supplementary Table S1). Data exhibited a
nonparametric distribution.
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Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart.
4.1.2. DBS parameters and Tremor Outcomes
The correlation coefficients of the stimulation parameters with time were r(1159) = −0.17,
r2 = 0.02 (2.89%), p < 0.001 for voltage, r(1312) = −0.17, r2 = 0.02 (2.89%) p < 0.001 for pulse width and
r(1258) = 0.08, r2 = 0.006 (0.6%) p < 0.05 for frequency. Overall, the average tremor suppression achieved by
DBS was 62.98% ± 16%, r(1466) = 0.16, r2 = 0.02 (2.56%), p < 0.001 (Supplementary Figure S1).
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4.1.3. Correlation of Stimulation Parameters and Tremor Suppression
Follow-up times were split into quartiles, which yielded four groups of tremor outcomes
corresponding to reports ranging from 3 to 6 months, 7 to 12 months, 13 to 30 months and 31
to 150 months, respectively. Although tremor outcomes differed significantly between the four
groups (χ2(3) = 186, p < 0.001), the means did not exhibit a consistent downward trend (M1 = 57.42,
95% CI: 55.78–59.08; M2 = 70.93, 95% CI: 69.8–72.02; M3 = 62.25, 95% CI: 60.47–64.14; M4 = 55.95,
95% CI: 53.73–58.16). Thus, no correction for the variable follow-up times was applied. Regarding the
interdependence of stimulation parameters and tremor, an inverse relationship is observed between
voltage r(1159) = −0.09, r2 = 0.008 (.81%), p < 0.05, and tremor. Although the same trend is observed
for pulse width r(1312) = −0.06, r2 = 0.003 (0.36%), p = 0.05, and frequency r(1258) = −0.03, r2 = 0.0009
(0.09%), p = 0.28, these are not statistically significant.
4.1.4. Side Effects
Thirty-seven of the 87 included studies reported side effects (N = 785). Namely, 7.89% of patients
complained of paresthesia (N = 62), 5.47% of gait and balance problems (N = 43), 2.03% of ataxia
(N = 16), 15.28% of dysarthria (N = 120) and 0.12% of diplopia (N = 1). Only voltage exhibited a
significant correlation, with dysarthria r(118) = 0.43, r2 = 0.43 (18.49%), p = 0.01.
4.2. Experimental DBS Programming
4.2.1. Experimental Tremor Titration
The experiment was conducted in eight ET patients (Table 1, Supplementary Figure S2). None of
the patients was on any tremor medication following DBS surgery. Baseline tremor control could not
be documented in one patient (ET6) and was excluded from the corresponding statistical analysis.
Given that subjective improvement was nevertheless achieved and sustained in the thr medium
term, ET6 is still documented in Table 1. The experimental paradigm showed significant tremor
reduction compared to baseline stimulation, according to both subjective (t(6) = −2.95, p = 0.02)
and objective (t(6) = −3.07, p = 0.02) measurements (Figure 2). Notably, the tremor improvement
perceived by the patients corresponded to the accelerometer measurements. On average, the results
were achieved after 23.8 ± 8.03 min per patient. Upon follow-up, 45% of the patients reported
medium-term tremor control superior to baseline (p = 0.01). None of the patients reported the new
setting as being worse than the previous. As far as side effects are concerned, four patients (ET2, ET4,
ET7, ET8) reported stimulation-induced ataxia and/or dysarthria at baseline. Following experimental
re-titration, side-effects were resolved in all but one patient (ET4), who reported re-emergence of ataxia
upon follow-up.
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Table 1. Patient demographics and deep brain stimulation (DBS) parameters. Baseline tremor control was measured prior re-titration with the patients retaining their
current DBS settings. Next, ten random combinations of stimulation parameters were tested in eight essential tremor (ET) patients. The random combinations affording
the most tremor suppression according to both patient-reported outcomes (subjective) and accelerometer recordings (objective) are presented here. Tremor severity is












V P F TDAmp V P F TDAmp V P F TDAmp
ET1 53 male Since youth 2 Vim −1 2 90 185 0.87 3.2 180 80 0.32 3.3 200 95 0.20
ET3 77 male 22 1 Vim −10 3 90 185 1.03 3.5 180 145 0.27 3.9 150 160 0.24
ET4 73 male 33 20 Vim −0 0.8 60 180 0.14 1.6 70 165 0.11 2.1 170 85 0.11
ET5 69 male 52 1 Vim −1/2+ 2.8 60 185 0.07 2.7 210 170 0.07 3.2 140 175 0.07
Average tremor improvement (%) compared to baseline for Vim-DBS according to subjective (53%) and objective (58%) measurements.
ET2 78 male Since youth 3 ZI −3 3.3 60 185 0.94 3.6 60 160 0.36 3.9 70 150 0.28
ET6 70 male 27 4 ZI −9/10+ 1.7 60 180 n.a. 1.5 90 155 0.43 1.5 90 155 0.43
ET7 72 female Since youth 6 ZI −1 1.8 90 180 1.07 2.2 140 140 0.20 2,2 140 140 0.20
ET8 51 female 48 6 ZI −1/2+ 1 90 185 1.81 2.2 160 180 0.11 1.5 220 180 0.06
Average tremor improvement (%) compared to baseline for ZI-DBS according to subjective (79%) and objective (82%) measurements.
Abbreviations: ET = essential tremor, F = frequency (Hz), TDAmp = arbitrary unit of measurement representing tremor severity, P = pulse width (µs), V = voltage (V), Vim = ventral
intermediate thalamic nucleus, ZI = zona incerta.




Figure 2. Experimental ET-DBS titration. Ten random combinations of stimulation parameters were 
tested and characterized subjectively (patient reported outcomes) and objectively (accelerometer 
measurements). The tremor outcomes during the experimental parameter exploration are categorized 
as follows: worst (least tremor reduction), off (stimulation turned off), baseline (initial settings), best 
subjective (best random settings according to the patient), best objective (best random settings 
according to accelerometer measurements). The novel programming strategy afforded significant 
tremor reduction (t(6) = −2.95, p = 0.02) in the absence of side-effects. (*) represents a statistically 
significant (p < 0.05) difference  
4.2.2. Random DBS Parameters 
An example of the randomly generated parameters is given in Supplementary Figure 2. 
Parameter optimization was achieved with significantly broader pulse widths according to both 
subjective Z = −2.37, p = 0.01 and objective Z = −2.52, p = 0.01 measurements. Conversely, significantly 
lower frequencies proved superior to baseline settings in both subjective Z = −2.53, p = 0.01 and 
objective ratings Z = −2.52, p = 0.01. No significant difference was detected for either subjective Z = 
−1.12, p = 0.26 or objective Z = −1.54, p = 0.12 ratings of voltage. More optimal tremor reduction was 
achieved with higher levels of TEED, in both subjective t(7) = −2.12, p = 0.07 and objective t(7) = −3.08, 
p = 0.01 measurements. 
5. Discussion 
5.1. Meta-Analysis 
Our meta-analysis shows that, in more than 30 years, the outcome of ET-DBS improved only 
modestly. Given that there was no relevant change in the studied DBS parameters, the observed 
improvement might possibly be attributed to improved patient selection [6], DBS targeting [7,21] and 
stereotactic planning [22]. Although beneficial, these developments are efficient mostly in the short-
term. Provided that tremor outcomes significantly decline over time [23], with habituation of the 
stimulation settings accounting for more than 10% of the decrease in outcome [24], more efforts 
Figure 2. Experimental ET-DBS titration. Ten random combinations of stimulation parameters were
tested and characterized subjectively (p ie t repo te out es) and objectively (accele o t
measur ments). The t emo outcomes during the experimen al parameter exploration are categoriz d
as follows: worst (least tremor reduction), off (stimulation turned off), baseline (initial settings),
best subjective (best andom settings accordi g to the patient), best objective (b st random setti s
according to accelerometer mea urements). The novel programming strategy afforded significant
tremor reduction (t(6) = −2.95, p = 0.02) in the absence of side-effects. (*) rep es nts a statistically
significant (p < 0.05) difference.
4.2.2. Random DBS Parameters
An example f the randomly g nerated parameters is given in Supplementary Figure S2. Parameter
optimization was achieved with significantly broader pulse widths according to both subjective
Z = −2.37, p = 0.01 and objective Z = −2.52, p = 0.01 measurements. Conversely, significantly lower
frequencies proved superior to baseline settings in both subjective Z = −2.53, p = 0.01 and objective
ratings Z = −2.52, p = 0.01. No significant difference was detected for either subjective Z = −1.12,
p = 0.26 or objective Z = −1.54, p = 0.12 ratings of voltage. More optimal tremor reduction was
achieved with higher levels of TEED, in both subjective t(7) = −2.12, p = 0.07 and objective t(7) = −3.08,
p = 0.01 measurements.
5. Discussion
5.1. Meta-Analysis
Our meta-analysis shows that, in more than 30 years, the outcome of ET-DBS improved only
modestly. Given that there was no relevant change in the studied DBS parameters, the observed
improvement might possibly be attributed to improved patient selection [6], DBS targeting [7,21]
and stereotactic planning [22]. Although beneficial, these developments are efficient mostly in the
short-term. Provided that tremor outcomes significantly decline over time [23], with habituation of the
stimulation settings accounting for more than 10% of the decrease in outcome [24], more efforts should
be focused on programming. In line with this, there is evidence for alternating stimulation settings to
reduce habituation. However, side-effects remain a great limiting factor.
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From the available literature, there appears to be no substantial relationship between DBS
parameters and tremor suppression or side-effects. Given that several follow-up reports extend up to
150 months, it raises the concern that tremor outcomes might be affected by either disease progression
or tremor adaption. Although tremor outcomes differed significantly in the four time-groups
(follow-up-duration quartiles), no downward trend suggesting declining outcomes was observed.
As such, the observed differences stem more likely from patient heterogeneity, rather than being the
effect of time. In line with these results, we introduced random combinations of stimulation parameters
for conducting comprehensive and time-saving parameter searches in individual patients. We show
that this novel programming strategy is effective in optimizing individual tremor control and resolving
side effects.
Despite that DBS parameters remain relatively constant over time, the corresponding tremor
outcomes show large variations. Although voltage is the only parameter to show a significant
correlation with tremor suppression and dysarthria, the low value of the explained variation falls
short to explain this observation (significance in this case reflects the large N rather than a clinical
significance) These findings confirm the inconsistent results from DBS-parameter explorations reported
elsewhere [25–27]. Such discrepancies suggest that uniform parameters might not exist, and that
programming should particularly address the individual anatomy [7] and tremor characteristics [25].
The Rationale behind Conventional Stimulation Parameters
Conventional stimulation parameters have originally been extrapolated from structure–effect
relationships to address the anatomical target and tremor characteristics [10,28]. However,
they consistently appear to fall short of the mark, with room for improving clinical outcomes.
Despite increasing evidence that better individualizing the DBS dose is key to maximizing symptom
control [17,27], conventional parameters have remained the mainstay. However, as long as the precise
spatiotemporal coordinates of the neuroanatomical substrate required for clinical benefits remain
insufficiently understood, finding the optimal DBS parameters will remain challenging.
Firstly, the complexity of stimulating neural tissue stems from multiple determinants, e.g.,
the interaction with different neuronal elements and relative distance to the electrode [29,30], as well
as the direction of propagation of the action potentials [31,32]. This is consistent with the difficulty of
modeling electric field predictions [33,34]. Secondly, this spatial component of DBS is further raveled by
the yet unknown mechanism of action. Several hypotheses have been proposed [35,36], illustrating the
wide-ranging effects of DBS. Elucidating the precise effects that determine the clinical outcome will
be key to refining the electric field predictions to address both the local and global dynamics of
the targeted circuitopathies. Lastly, the third obstacle in finding optimal DBS parameters are the
temporal adjustments of stimulation. Refining DBS to be delivered only in response to pathological
biomarkers (adaptive DBS; aDBS) appears promising for both ameliorating symptoms and reducing
side-effects [37,38].
Attempts to understand the stimulation parameters have yielded inconsistent results.
Most commonly, the effect of varying one DBS-parameter is documented, while the remaining
parameters are maintained at constant [39]. The limitation of such an approach is that the constant
parameters determine the therapeutic window of the parameter of interest [16]. This generates
irreproducible results due to inter-patient variability. In this study, we emphasize how insufficiently
understood the interdependence of the stimulation parameters is, i.e., unexpected stimulation
parameters can be clinically meaningful only when provided with the right interaction of these
three parameters. Given that (1) the stimulation substrate exhibits a highly complex, dynamic and
individualized spatiotemporal fabric and that (2) individual stimulation parameters cannot be
considered for titration alone, future studies should allow for mutual dynamism to be exercised
between the two. Therefore, programming strategies should be as robust as possible.
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5.2. Experimental DBS Programming
Increasing understanding of the complexity of the stimulation substrate, as well as that of the
interdependence of the stimulation parameters, has increasingly discouraged the use of conventional
parameters. However, the infeasibility of clinically exploring the range of DBS parameters, to a greater
extent, has precluded this transition. Testing ten random combinations of stimulation parameters results
in a thorough, time-saving exploration, which allows for ET-DBS optimization in individual patients.
Safety is ensured by gradually transitioning between combinations and having the patient report
the emergence of side effects, beyond which stimulation is not further increased. Notably, the most
optimal parameters are selected by patient intrinsic factors, e.g., anatomopathological substrate [40–42]
and lead positioning [16,43]. The fact that significantly lower frequencies have been favored in this
assumption-free trial is in line with the observed deleterious effects of supra-threshold frequency [14].
It is also tempting to attribute the resolution of side-effects in three of our four patients to this. This pilot
approach raises thus great interest by opening the gate towards more individualized, comprehensive,
and faster DBS titration.
The foremost limitations of the meta-analysis are publication bias [4] and perhaps overly
enthusiastic early reports [44]. Additionally, the analysis of the relationship between DBS parameters
and tremor outcomes could have benefited from objective tremor measurements (e.g., accelerometry).
Nevertheless, validated tremor scales have been used [45]. Regarding the experiment, one limitation
might be using shorter (between 1–2 min) wash-out periods than usual [18] in some patients. However,
it has been shown that Vim-DBS for ET provides tremor suppression over seconds [2]. Additionally,
the sustained tremor suppression upon follow-up excluded that the therapeutic benefit of the definitive
experimental settings was confounded by phase-resetting or carryover effects. In addition, it would
have been desirable to also provide tremor scores. However, the value of tremor scales would have
been limited in this case, given that only one posture of one limb was assessed and tremor scales
cannot detect subtle differences due to their ordinal character. Ideally, medium-term tremor reports
should have been supplemented by accelerometer measurements. Another limitation might be using
pre-determined electrode configurations. This was done because the electrode configurations with the
largest therapeutic windows had already been determined in previous programming sessions and we
wanted to limit patient fatigue to a minimum. However, it would be interesting, in a future study,
to explore the role of random stimulation parameters in determining the therapeutic window. Lastly,
there is no evidence that, after ten trials of random parameters, convergence is reached. However,
we started with a pragmatic approach that could be tested during a regular outpatient visit. In future
studies, we will explore whether testing more parameters brings further improvements.
6. Conclusions
DBS programming provides options beyond conventional parameter selection. Access to these
parameters is particularly important for addressing ET that does not respond to conventional DBS
parameters [12] or develops habituation [13,24]. Deep-learning modalities might be able to further
refine this approach to avoid supra-therapeutic stimulation, minimize battery consumption, and enable
the titration of more complex devices [46,47]. The role of the individual DBS parameters in tremor
control remains elusive. Our proof of concept underscores the interdependence of voltage, pulse width,
and frequency, warranting further research.
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